The safety of Bruton's tyrosine kinase inhibitors in B-cell malignancies: A systematic review

Michael Arustamyan, Pavel Kibrik, Dilara Hatipoglu, Brandon Bungo, Amgad Mentias, Brian T. Hill, Rohit Moudgil*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'The safety of Bruton's tyrosine kinase inhibitors in B-cell malignancies: A systematic review'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology